Gregory P Bisson - JoVE Visualize

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Lancet (London, England)|March 31, 2016

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trialMina C Hosseinipour, Gregory P Bisson, Sachiko Miyahara, et al.

Open Forum Infectious Diseases|January 16, 2026

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024Rina Liang, James C M Brust, Caitlin Reed, et al.

Lancet (London, England)|September 15, 2018

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis, Nafees Ahmad, Shama D Ahuja, et al.

Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Lancet (London, England)|March 31, 2016

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trialMina C Hosseinipour, Gregory P Bisson, Sachiko Miyahara, et al.

Open Forum Infectious Diseases|January 16, 2026

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024Rina Liang, James C M Brust, Caitlin Reed, et al.

Lancet (London, England)|September 15, 2018

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis, Nafees Ahmad, Shama D Ahuja, et al.

Pageof 8